Endothelial nitric oxide synthase (eNOS) G894T polymorphism is not associated with breast cancer risk: new evidence
Letter to the Editor
- 116 Downloads
KeywordsOxide Breast Cancer Confidence Interval Nitric Oxide Large Sample Size
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This study was supported by Administration of Traditional Chinese Medicine of Zhejiang Province (2007CA113).
- 4.Choi JY, Barlow WE, Albain KS, Hong CC, Blanco JG, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF (2009) Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a southwest oncology group clinical trial. Clin Cancer Res 15(16):5258–5266PubMedCrossRefGoogle Scholar
- 5.Ahn J, Ambrosone CB, Kanetsky PA, Tian C, Lehman TA, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J (2006) Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clin Cancer Res 12(23):7063–7070PubMedCrossRefGoogle Scholar
- 7.Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, Rodriguez C, Thun MJ, Calle EE (2007) Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 16(9):1784–1794PubMedCrossRefGoogle Scholar
© Springer Science+Business Media, LLC. 2011